Upgrade to SI Premium - Free Trial

Nanobiotix S.A. (NBTX)

39.70 +0.15 (0.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/30/26)

Latest Headlines

Nanobiotix S.A (NBTX) PT Raised to $46 at Leerink June 4, 2026 4:02 AM - StreetInsider NANOBIOTIX closes global offering, raises $100 million May 26, 2026 4:51 PM - StreetInsider NANOBIOTIX Announces Closing of Global Offering May 26, 2026 4:44 PM - Globe NewsWire Nanobiotix prices €85 million global offering of shares and warrants May 21, 2026 11:01 AM - StreetInsider Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering May 21, 2026 10:57 AM - Globe NewsWire Nanobiotix reports early lung cancer trial data for JNJ-1900 treatment May 17, 2026 10:15 AM - StreetInsider Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer May 17, 2026 10:15 AM - Globe NewsWire Nanobiotix announces FDA accepts protocol changes to cancer study May 4, 2026 5:29 PM - StreetInsider Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study May 4, 2026 5:29 PM - Globe NewsWire Nanobiotix S.A (NBTX) PT Raised to $30 at UBS May 1, 2026 6:24 AM - StreetInsider Full Article List